Caribou Biosciences, Inc. CRBU
0.46 USD +0.02 (+4.43%)
At closeNov 3, 2026, 6:40 PM EST
0.45 0.00 -1.07%
After hours · Nov 3, 6:40 PM ET
0.415 Day range 0.4646
0.41 52-week range 2.49
- YTD
- -71.11%
- 1 year
- -81.09%
Financial health
Altman Z-Score
-7.22 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -1.0×
FY 2019 5y median -3.8× FY 2025
P/S 13.3×
FY 2019 5y median 14.4× FY 2025
P/B 1.2×
FY 2019 5y median 1.2× FY 2025
P/FCF -1.3×
FY 2019 5y median -3.9× FY 2025
EV/EBITDA -1.1×
FY 2019 5y median -3.6× FY 2025
EV/Sales 14.6×
FY 2019 5y median 15.4× FY 2025
FCF Yield -75.7%
FY 2019 5y median -25.7% FY 2025
Profitability
Gross Margin 67.3%
FY 2019 5y median 73.7% FY 2025
Operating Margin -1220.5%
FY 2019 5y median -768.2% FY 2025
Net Margin -1327.4%
FY 2019 5y median -717.8% FY 2025
ROE -121.2%
FY 2019 5y median -33.0% FY 2025
ROIC -89.8%
FY 2019 5y median -30.7% FY 2025
ROA -84.5%
FY 2019 5y median -26.6% FY 2025
Growth (YoY)
Revenue 11.7%
FY 2019 FY 2025
Operating Income 18.3%
FY 2019 FY 2025
EPS (diluted) 3.6%
FY 2019 FY 2025
Free Cash Flow 22.4%
FY 2019 FY 2025
Financial Health
Current Ratio 5.7×
FY 2019 5y median 9.3× FY 2025
Quick Ratio 5.7×
FY 2019 5y median 9.3× FY 2025
Debt / Equity 0.2×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2019 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31